An increased incidence of cancer in immunodeficient and immunosuppressed\break patients is now well established. Improvements in transplantation procedures and immunosuppressive therapies have resulted in better short-term and long-term graft survival, but immunosuppression exposes patients to long-term complications [1]. Malignancies are becoming the greatest limiting factor for patient and graft survival following kidney transplantation, even as incidence of death related to cardiovascular diseases and infections is decreasing [2]. Cancers are frequently more aggressive in transplant patients and are more likely to be fatal than would be expected in patients who have not undergone transplantation [3].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342:605–612.
ANZDATA. Australian and New Zealand Dialysis and Transplant Registry. 2006. Available at http://www.anzdata.org.au/.
Barrett W, First M, Aron B, Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993; 72:2186–2189.
Dantal J, Hourmant M, Cantarovich D et al. Effect of long term immunosuppression in kidney graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351:623–628.
Montagnino G, Lorca E, Tarantino A et al. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996; 10:461–469.
Hiesse C, Rieu P, Kriaa F et al. Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proc 1997; 29:831–833.
Rinaldi M, Pellegrini C, D’Armini A et al. Neoplastic disease after heart transplantation: single center experience. Eur J Cardiothorac Surg. 2001; 19: 696–701.
Buccianti G, Ravasi B, Cresseri D et al. Cancer in patients on renal replacement therapy in Lombardy, Italy. Lancet 1996; 347:59–60.
Adami J, Gabel H, Lindelof B et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89:1221–1227.
Pedotti P, Cardillo M, Rossini G et al. Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation 2003; 76:1448–1451.
Andres A. Cancer incidences after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol 2005; 56:71–85.
Sheil AG. Patterns of malignancies following renal transplantation. Transplant Proc 1999; 31:1275–1279.
Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905–913.
Taylor D, Edwards L, Boucek M et al. Registry of the International Society of Heart and Lung Transplantation: Twenty second official adult heart transplanted report 2005. J Heart Lung Transplant 2005; 4:945–955.
Ulrich C, Schmook T, Sachse M et al. Comparative epidemiology and pathogenic factors for non-melanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30:622–627.
Euvrard S, Kanitakis J, Decullier E et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81:1093–1100.
Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4:222–230.
Oo Y, Gunson B, Lancashire R et al. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005; 80:759–764.
Sheiner P, Magliocca J, Bodian C et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000; 69:781–789.
Haagasma E, Hagens V, Schaapveld M et al. Increased cancer risk after liver transplantation: a population-based study. Hepatology 2001; 34:161–164.
Penn I. Post transplant malignancies; the role of immunosuppression. Clin Transplant 1998; 1:147–158.
Penn I. Post transplantation malignancies. Transplant Proc 1999; 31:1260–1262.
Birkeland S, Storm H, Lamm L et al. Cancer risk after renal transplantation in Nordic countries. Int J Cancer 1995; 60:183–189.
Sheil A. Cancer in dialysis and transplanted patients. In: Morris JP (ed) Kidney Transplantation Principles. Philadelphia: Saunders, 2001:558–570.
Port F, Ragheb N, Schwartz A et al. Neoplasms in dialysis patients: a population based study. Am J Kidney Dis 1989; 14:119–123.
Maisonneuve P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end stage renal disease: an international collaborative study. Lancet 1999; 354:93–99.
Vajdic C, McDonald S, McCredie et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296:2823–2831.
Kessler M, Jay N, Guillemon F. Excess risk of cancer in renal transplant patients. Transplant Int 2006; 19:908–914.
Potaris K, Radovancevic B, Thomas C et al. Lung cancer after heart transplantation: a 17-year experience. Ann Thorac Surg 2005; 79:980–983.
Goldstein DJ, Austin JH, Zuech N et al. Carcinoma of the lung after heart transplantation. Transplantation 1996; 62:772–775.
Rinaldi M, Pellegrini C, D’Armini A et al Neoplastic disease after heart transplantation: single center experience. Eur J Cardiothorac Surg 2001; 19:696–701.
Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993; 12:S328–S336.
Rosenbaum DH, Bhojani RA, Dikmen E et al. Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival. J Heart Lung Transplant 2005; 24:2043–2047.
Fabia R, Levy M, Testa G et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998 ; 176:265–269.
Dvorchik I, Subotin M, Demetris A et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology 2002; 35:380–384.
Sanchez EQ, Marubashi S, Jung G et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transplant 2002; 8:285–291.
Briceno J, Lopez-Cillero P, Fraga E, Pera C. Results of liver transplantation in a Spanish group: a report from the Cordoba unit. Clin Transplant 2001; 2:187–194.
Duvoux C, Delacroix I, Richardet JP et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 1999; 67:418–421.
Fung J, Jain A, Kwak E et al. De novo malignancies after liver transplantation: a major cause of late death. Liver Transplant 2001; 7:S109–S118.
Aroldi A, Lampertico P, Montagnino G et al. Natural history of hepatitis B and C in renal allograft recipients. Transplantation 2005; 79:1132–1136.
Kelly DM, Emre S, Guy SR et al. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 1998; 83:1237–1243.
Benlloch S, Berenguer M, Prieto M et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004; 4:596–604.
Danpanich E, Kasiske BL. Risk factors for cancer in renal transplant recipients. Transplantation 1999; 68:1859–1864.
Muller AM, Ihorst G, Mertelsmann R et al. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005; 84:1–12.
Rezaee SA, Cunningham C, Davison AJ et al. Kaposi’s sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol 2006; 87:1781–1804.
Majewski S, Jablonska S. Current views on the role of human papillomaviruses in cutaneous oncogenesis. Int J Dermatol 2006; 45:192–196.
Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004; 127:S56–S61.
Swinnen L, Costanzo-Nordin M, Fisher S et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990; 323:1723–1728.
Wilkinson A, Smith J, Hunsicker L et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 1989; 47:293–296.
Kliem V, Kolditz M, Behrend M et al. Risk of renal cell carcinoma after kidney transplantation. Clin Transplant 1997; 11:255–258.
Wu M, Lian J, Yang C et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 2004; 43:1091–1097.
Goldfarb D, Neumann H, Penn I. Results of renal transplantation in patients with renal cell carcinoma and von Hippel–Lindau disease. Transplantation 1997; 64:1726–1729.
Cleper R, Davidovitz M, Krause I et al. Unexpected Wilms’ tumor in a pediatric renal transplant recipient: suspected Denys–Drash syndrome. Transplant Proc 1999; 31:1907–1909.
Gomez E, Portal CG, Seco MA, Alvarez-Grande J. Multiple solid malignancies in a renal transplant patient. Nephrol Dial Transplant 1999; 14:803–804.
Barroso-Vicens E, Ramirez G, Rabb H. Multiple primary malignancies in a renal transplant patient. Transplantation 1996; 61:1655–1666.
Nagele H, Kalmar P, Rodiger W, Stubbe HM. Smoking after heart transplantation: an underestimated hazard? Eur J Cardiothorac Surg 1997; 12:70–74.
Sturgis EM, Wei Q, Spitz MR. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 2004; 31:726–733.
Lipworth L, Tarone R, McLaughlin J. The epidemiology of renal cell carcinoma. J Urol 2006; 176:2353–2358.
Pelucchi C, Bosetti C, Negri E at al. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 2006; 3:327–340.
Qiu D, Kurosawa M, Lin Y et al. Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol 2005; 1:S157–167.
Moore TO, Moore AY, Carrasco D, Vander Straten M, Arany I, Au W, Tyring SK. Human papillomavirus, smoking, and cancer. J Cutan Med Surg 2001; 5:323–328.
Ramsay H, Fryer A, Hawley CM et al. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49:397–406.
Hoshida Y, Tsukuma H, Yasunaga Y et al. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71:517–520.
Hoshida Y, Aozasa K. Malignancies in organ transplant recipients. Pathol Int 2004; 54:649–658.
67. Feng WW, Wang TN, Chen HC et al. Malignancies after renal transplantation in southern Taiwan: experience in one centre. BJU Int 2006; 97.
Alzahrani A, El-Harith el-H, Milzer J et al. Increased seroprevalence of human herpes virus-8 in renal transplant recipients in Saudi Arabia. Nephrol Dial Transplant 2005; 20:2532–2536.
Girndt M, Kohler H. Waiting time for patients with history of malignant disease before listing for organ transplantation. Transplantation 2005; 80:S167–S170.
Penn I. Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 1997; 2:14–17.
Taioli E, Piselli P, Arbustini E et al. Incidence of second primary cancer in transplanted patients. Transplantation 2006; 81:982–985.
Demeter J, Lehoczky D. Splenectomy and the risk of developing leukemia. J Clin Oncol 1993; 11:2287.
Mellemkjoer L, Olsen J, Linet M et al. Cancer risk after splenectomy. Cancer 1995; 75:577–583.
Linet MS, Nyren O, Gridley G et al. Risk of cancer following splenectomy. Int J Cancer 1996; 66:611–616.
Birkeland S, Lokkegaard H, Storm H, et al. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355:1886–1887.
Dickson RP, Davis RD, Rea JB, Palmer SM. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 2006; 25:1297–1301.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Dantal, J. (2009). De Novo Post-Transplantation Malignancies: Incidence and Risk Factors. In: Stockfleth, E., Ulrich, C. (eds) Skin Cancer after Organ Transplantation. Cancer Treatment and Research, vol 146. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-78574-5_3
Download citation
DOI: https://doi.org/10.1007/978-0-387-78574-5_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-78573-8
Online ISBN: 978-0-387-78574-5
eBook Packages: MedicineMedicine (R0)